Final Exam PUP Flashcards
Which of the following is the brand name for losartan?
a. Norvasc
b. Cozaar
c. Lasix
d. Lopressor
b. Cozaar
Which is the brand name for warfarin?
a. Aldactone
b. Coumadin
c. Cozaar
d. Xarelto
b. Coumadin
which of the following are common strengths for levothyroxine (SELECT ALL THAT APPLY)?
a. 100mcg
b. 112mcg
c. 125mcg
d. 137mcg
a,b,c,d
which are common strengths for methylprednisolone (SELECT ALL THAT APPLY)?
a. 4 mg
b. 8 mg
c. 16 mg
d. 32 mg
a,b,c,d
what are the big 4 prescribers?
physicians (MD or DO)
dentists (DDS or DMD)
podiatrists (DPM)
veterinarians (DVM)
what do the first 5 numbers of the NDC identify?
the manufacturer (# is assigned by the FDA)
what do the middle 4 numbers of the NDC refer to?
drug, strength, dosage form, and formulation of the product (assigned by the manufacturer)
what do the last 2 numbers of the NDC refer to?
package size (assigned by the manufacturer)
a schedule 1 drug has
a. limited abuse potential, and /or physical, psychological dependence
b. medical use, medium abuse and addiction potential
c. no medical use, highest abuse potential, unsafe
c. no medical use, highest abuse potential, unsafe
a schedule 2 drug has
a. medical use, high abuse potential, highly addictive
b. medical use, low-med abuse and addiction potential
c. medical use, medium abuse and addiction potential
a. medical use, high abuse potential, highly addictive
a schedule 3 drug has
a. medical use, medium abuse and addiction potential
b. limited abuse potential, and/or physical, psychological dependence
c. no medical use, highest abuse potential, unsafe
a. medical use, medium abuse and addiction potential
a schedule 4 drug has
a. medical use, medium abuse and addiction potential
b. limited abuse potential, and/or physical, psychological dependence
c. no medical use, highest abuse potential, unsafe
d. medical use, low-med abuse and addiction potential
d. medical use, low-med abuse and addiction potential
a schedule 5 drug has
a. no medical use, highest abuse potential, unsafe
b. medical use, high abuse potential, highly addictive
c. medical use, medium abuse and addiction potential
d. medical use, low-med abuse and addiction potential
e. limited abuse potential, and/or physical, psychological dependence
e. limited abuse potential, and/or physical, psychological dependence
CIII, IV, and V drugs expire no later than ___ months from issue date
6
how many refills can a CIII, IV, and V drug have max?
5 refill max
all non-controlled prescriptions in Indiana expire, at the latest, ___ ___ from the date of issue, unless there are additional prescriber prescriptions
one year
medicare part A
a. outpatient, few meds
b. “advantage” plan, deductible coverage, increasing Rx coverage
c. hospital
c. hospital
medicare part B
a. outpatient, few meds
b. “advantage” plan, deductible coverage, increasing Rx coverage
c. hospital
a. outpatient, few meds
medicare part C
a. outpatient, few meds
b. “advantage” plan, deductible coverage, increasing Rx coverage
c. hospital
b. “advantage” plan, deductible coverage, increasing Rx coverage
CIII, IV, and V prescriptions can be transferred how many times as long as it has been filled at least once?
one time only
exception for transferring CIII, IV, and V prescriptions
receiving and sending pharmacies share a common database
a private entity focused on increasing safety of healthcare practice
through documentation of how/why medication errors occur,
communicating trends to the healthcare community, and developing
best practices
a. institute of safe medication practices (ISMP)
b. food and drug administration (FDA) MedWatch
a. institute of safe medication practices (ISMP)
a government agency interested in product failures and serious
adverse events for all types of medications, medical devices, and
foods, which publishes recalls issued by manufacturers
a. institute of safe medication practices (ISMP)
b. food and drug administration (FDA) MedWatch
b. food and drug administration (FDA) MedWatch
class 1 drug recall
a. Drug product may
cause serious
adverse health
consequences
including death
(pharmacies
notify patients
who received
recalled drugs)
b. Drug may cause
temporary or
reversible effects,
but the probability
of serious health
consequences is
remote.
c. Drug product is
unlikely to cause
serious adverse
health
consequences.
a. Drug product may
cause serious
adverse health
consequences
including death
(pharmacies
notify patients
who received
recalled drugs)
most severe drug recall
a. class I
b. class II
c. class III
a. class I
least severe drug recall
a. class I
b. class II
c. class III
c. class III
FDA seizure vs DEA seizure
-FDA may physically isolate a drug that is adulterated or misbranded while a civil lawsuit is filed
-DEA may physically isolate a drug that is illegal to possess or distribute while a criminal lawsuit is filed, with probable
cause and a warrant when necessary.
Which of the following medications does NOT have an indication for chronic nasal allergy symptoms?
a. symbicort
b. flonase
c. singulair
a. symbicort
Which of the following medications is indicated for the treatment of premenstrual dysphoric disorder?
a. escitalopram
b. duloxetine
c. venlafaxine
d. fluoxetine
d. fluoxetine
(Sarafem only)
Which of the following medications is indicated for migraine prevention?
a. clopidogrel
b. losartan
c. lisinopril
d. furosemide
c. lisinopril
Which of the following medications is NOT indicated for the treatment of heart failure?
a. spironolactone
b. lisinopril
c. metoprolol tartrate
d. losartan
c. metoprolol tartrate
Which of the following medications is used to treat moderate pain?
a. hydrocortisone
b. tramadol
c. methylprednisolone
d. oxycodone
b. tramadol
Which of the following medications is NOT commonly used to treat anxiety?
a. duloxetine
b. venlafaxine
c. escitalopram
d. bupropion
d. bupropion
common strength for omega 3 fatty acid
1 g
